SEPTEMBER IS BLOOD CANCER AWARENESS MONTH
Impactful research leads to impactful outcomes
MPN Research Foundation
Partner. Advocate. Friend. At the MPN Research Foundation, we’re committed to standing with you in the fight against polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis (MF) – the group of blood cancers collectively known as myeloproliferative neoplasms.
PROVIDING EDUCATION AND RESOURCES FOR A BETTER TODAY. INVESTING IN RESEARCH FOR A BETTER TOMORROW.
MPNRF By the Numbers
What is Primary Myelofibrosis (MF)?
What is Essential Thrombocythemia (ET)?
Essential Thrombocythemia (ET)
Most commonly diagnosed in women over the age of 50, ET is associated with a proliferation of platelet precursors in the bone marrow and complications frequently include blood clotting and/or bleeding.
What is Polycythemia Vera (PV)?
Polycythemia Vera (PV)
The disease is most common in men over the age of 60, but anyone can develop PV. PV patients typically experience an elevated red blood cell count, an elevated platelet count and an enlarged spleen, especially over time.
With an orphan disease, the support can be hard to find. I found that support at the MPN Research Foundation.
JUAN ALDERETE, PV 06
Ready to do more?
Julie and her family joined team MPN and created HikeMF to join the fight against MPNs.
With your generous gift, you can change a MPN patient’s prognosis.
By supporting MPN Research Foundation, you’re also supporting countless doctors and researchers around the world who are working to find a cure for these rare diseases.